Cardiovascular Pharmacology

Cardiovascular pharmacology focuses primarily on medications used in cardiovascular disease treatment, both existing and emerging groups of drugs.


The Cardiovascular Physiology and Pharmacology of Endothelin-I | Vascular Pharmacology of Epoxyeicosatrienoic Acids | Prostaglandins in Action | TP Receptors and Oxidative Stress | Regulation of Endothelial Cell Tetrahydrobiopterin | Polyphenol-Induced Endothelium-Dependent Relaxations | Organic Nitrates and Nitrate Tolerance | Vascular Actions of Adipokines | Cardiovascular Effects of Erythropoietin

Market Statistics:

By 2022, the global cardiovascular medicines market is expected to have grown from $141.1 billion in 2017 to $149.4 billion, representing a compound annual growth rate (CAGR) of 1.2 percent between 2017 and 2022.

Cardiovascular illnesses are one of the most common causes of death throughout the world. Following the American Heart Association's estimates, around 41.5 percent of the United States' population was suffering from some type of cardiovascular disease in 2015. This prevalence is expected to rise to 45 percent by 2035, according to the American Heart Association. Patients suffering from cardiovascular diseases are projected to increase in number as a result of a more sedentary lifestyle, shifting food habits, and an increase in risk factors.